hypotension

Updated: October 17, 2022

Background

Epidemiology

Anatomy

Pathophysiology

Etiology

Genetics

Prognostic Factors

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

ephedrine

Anesthesia induced: 5-10 mg IV bolus; to maintain BP repeat as needed Do not exceed a dose of 50 mg

ephedrine

Anesthesia induced: 5-10 mg IV bolus; to maintain BP repeat as needed Do not exceed a dose of 50 mg

norepinephrine

Initially: 8-12 mcg/min Intravenous infusion; following titrate to the effect
Maintenance: 2-4 mcg/min Intravenous infusion

epinephrine

Administer intravenous infusion at a rate of 0.05 to 2 mcg/kg/minute and adjust as necessary to attain the targeted mean arterial pressure (MAP). The dosage may be modified at regular intervals, for every 10 to 15 minutes, in increments of 0.05 to 0.2 mcg/kg/minute to achieve the desired blood pressure objective.

metaraminol

Initially, 15-100 mg in 0.9% of 0.5L NaCl or 5% dextrose infusion through infusion
Adjust the dose 10 minutes later to maintain the blood pressure

isocorynoxeine

In vivo studies suggest that 40 mg/kg administered orally has proven to be effective in rats

Indications: It is claimed to possess anti-spasmodic and sedative effects. It is also known to cause vasodilation, reduce blood pressure, etc

ephedrine

Body surface area (BSA): 0.5 mg/kg or 16.7 mg/m2 IM or SC every 4-6 hours

norepinephrine

Initially: 0.05-0.1 mcg/kg/min Intravenous infusion; titrate to the effect
Maximum dose: 1-2 mcg/kg/min

levarterenol

Initial dose: 0.05 mcg/min to 0.1 mcg/min intravenous infusion, titrate to the effect

Maintenance dose: 1 mcg/min to 2 mcg/min intravenous infusion

Future Trends